OTC Markets OTCPK - Delayed Quote USD

BioElectronics Corporation (BIEL)

0.0002

0.0000

(0.00%)

As of 10:10:43 AM EST. Market Open.

Sree Koneru, PhD Joins the Board of Directors of BioElectronics Corporation

FREDERICK, Md., Dec. 03, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL, a developer of medical technology products, today announces that Sree Koneru, PhD, will join its Board of Directors, effective December 3, 2024. Upon Dr. Koneru’s appointment, the Board will consist of three members, including Kelly Whelan, President of BioElectronics, and its Chairman, Richard Staelin, PhD. "We are honored to welcome Sree Koneru to the Board. Sree brings a rich dep

GlobeNewswire last month

BIEL
0.00%
BioElectronics Corporation's Chairman Updates Investors

Outlines Sales Activities, Clinical Trials, and a Potential Legal Action Against MundiPharma FREDERICK, Md., Oct. 16, 2024 (GLOBE NEWSWIRE) -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today releases an update from its Chairman, Richard Staelin, PhD. Dear Shareholders, It has been a while since I provided an update on BioElectronics Corporation's activities. Below are some of the most significant. Current Medical (RecoveryRx) Sale

GlobeNewswire 3 months ago

BIEL
0.00%
BioElectronics Corporation Announces Utility Patent Application Filing

Non-Invasive Device Addresses the Treatment of Chronic Inflammation FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the filin...

NewMediaWire 8 months ago

BIEL
0.00%
BioElectronics Corporation Announces the Publication of a Canine Arthritis Study

96% of the Dogs Treated With the Active Model 088 Device Showed Marked Improvement FREDERICK, MD, March 25, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL) a developer of medical technology products, announces the results and publication of a study investigating the efficacy of its FDA-cleared pulsed-shortwave-therapy (PSWT)device in initiating a systemic anti-inflammatory response to improve functionality of canines diagnosed with os

GlobeNewswire 10 months ago

BIEL
0.00%
BioElectronics Corporation Announces the Publication of Pilot Study Results

Beneficial Treatment Effect for Phantom and Residual Limb Pain Identified FREDERICK, MD, Feb. 23, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the publication of a study investigating the treatment of phantom and residual limb pain using its pulsed shortwave therapy device. "Treating intractable postamputation pain with wearable, non-invasive, non-thermal, pulsed shortwave (

GlobeNewswire 11 months ago

BIEL
0.00%
BioElectronics Chairman Updates Investors

Discusses Clinical Trial Progress and Potential Legal Action Against MundiPharma FREDERICK, MD, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today releases an update from its Chairman, Richard Staelin, PhD. The intent of this short update is to provide potential investors and current stockholders as much information as possible on the progress of our Company over these last three m

GlobeNewswire 11 months ago

BIEL
0.00%

Performance Overview

Return	BIEL	S&P 500
YTD	-33.33%	+2.67%
1-Year	-33.33%	+23.07%
3-Year	-81.82%	+36.84%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

BioElectronics Corporation (BIEL)

Sree Koneru, PhD Joins the Board of Directors of BioElectronics Corporation

BioElectronics Corporation's Chairman Updates Investors

BioElectronics Corporation Announces Utility Patent Application Filing

BioElectronics Corporation Announces the Publication of a Canine Arthritis Study

BioElectronics Corporation Announces the Publication of Pilot Study Results

BioElectronics Chairman Updates Investors

Performance Overview